Qiying Yi

Dr. Qiying Yi


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 October 2019 in BioMedical Engineering OnLine
Verified
Journal Article
Open access
PDF file
SHSirong He
Sirong He
DSDan Shi
Dan Shi
ZHZhigang Han
Zhigang Han
Zhaoming DongZhaoming Dong
Zhaoming Dong
YXYajun Xie
Yajun Xie
QYQiying Yi
Qiying Yi
Background: Silk fibroin hydrogel, derived from Bombyx mori cocoons, has been shown to have potential effects on wound healing due to its excellent biocompatibility and less immunogenic and biodegradable properties. Many studies suggest silk fibroin as a promising material of wound dressing and it can support the adhesion and proliferation of a variety of human cells in vitro. However, lack of translational evidence has hampered its clinical applications for skin repair. Herein, a heparin-immobilized fibroin hydrogel was fabricated to deliver FGF1 (human acidic fibroblast growth factor 1) on top of wound in rats with full-thickness skin excision by performing comprehensive preclinical studies to fully evaluate its safety and effectiveness. The wound-healing efficiency of developed fibroin hydrogels was evaluated in full-thickness wound model of rats, compared with the chitosan used clinically. Results: The water absorption, swelling ratio, accumulative FGF1 releasing rate and biodegradation ratio of fabricated hydrogels were measured. The regenerated fibroin hydrogels with good water uptake properties rapidly swelled to a 17.3-fold maximum swelling behavior over 12 h and a total amount of 40.48 ± 1.28% hydrogels was lost within 15 days. Furthermore, accumulative releasing data suggested that heparinized hydrogels possessed effective release behavior of FGF1. Then full-thickness skin excision was created in rats and left untreated or covered with heparinized fibroin hydrogels-immobilized recombinant human FGF1. The histological evaluation using hematoxylin and eosin (HE) and Masson’s trichrome (MT) staining was performed to observe the dermic formation and collagen deposition on the wound-healing site. To evaluate the wound-healing mechanisms induced by fibroin hydrogel treatment, wound-healing scratch and cell proliferation assay were performed. it was found that both fibroin hydrogels and FGF1 can facilitate the migration of fibroblast L929 cells proliferation and migration. Conclusion: This study provides systematic preclinical evidence that the silk fibroin promotes wound healing as a wound-healing dressing, thereby establishing a foundation toward its further application for new treatment options of wound repair and regeneration.

Verified
Journal Article
Open access
PDF file
LXLei Xu
Lei Xu
HXHua Xia
Hua Xia
YXYajun Xie
Yajun Xie
YHYanxia Hu
Yanxia Hu
JLJianing Liu
Jianing Liu
YXYajun Xie
Yajun Xie
High-dose dexamethasone (DEX) is used to treat chemotherapy-induced nausea and vomiting or to control immunotherapy-related autoimmune diseases in clinical practice. However, the underlying mechanisms of high-dose DEX in tumor progression remain unaddressed. Therefore, we explored the effects of high-dose DEX on tumor progression and the potential mechanisms of its anti-tumor function using immunohistochemistry, histological examination, real-time quantitative PCR (qPCR), and Western blotting. Tumor volume, blood vessel invasion, and levels of the cell proliferation markers Ki67 and c-Myc and the anti-apoptotic marker Bcl2 decreased in response to high-dose DEX. However, the cell apoptosis marker cleaved caspase 3 increased significantly in mice treated with 50 mg/kg DEX compared with controls. Some genes associated with immune responses were significantly downregulated following treatment with 50 mg/kg DEX e.g., Cxcl9, Cxcl10, Cd3e, Gzmb, Ifng, Foxp3, S100a9, Arg1, and Mrc1. In contrast, the M1-like tumor-associated macrophages (TAMs) activation marker Nos2 was shown to be increased. Moreover, the expression of peroxisome proliferator-activated receptors α and γ (Pparα and Pparg, respectively) was shown to be significantly upregulated in livers or tumors treated with DEX. However, high-dose DEX treatment decreased the expression of glucose and lipid metabolic pathway-related genes such as glycolysis-associated genes (Glut1, Hk2, Pgk1, Idh3a), triglyceride (TG) synthesis genes (Gpam, Agpat2, Dgat1), exogenous free fatty acid (FFA) uptake-related genes (Fabp1, Slc27a4, and CD36), and fatty acid oxidation (FAO) genes (Acadm, Acaa1, Cpt1a, Pnpla2). In addition, increased serum glucose and decreased serum TG and non-esterified fatty acid (NEFA) were observed in DEX treated-xenografted tumor mice. These findings indicate that high-dose DEX-inhibited tumor progression is a complicated process, not only activated by M1-like TAMs, but also decreased by the uptake and consumption of glucose and lipids that block the raw material and energy supply of cancer cells. Activated M1-like TAMs and inefficient glucose and lipid metabolism delayed tumor cell growth and promoted apoptosis. These findings have important implications for the application of DEX combined with drugs that target key metabolism pathways for tumor therapy in clinical practice.

31 October 2018 in Drug Development Research
Verified
Journal Article
Closed access
PDF file
XJXin Jin
Xin Jin
TZTingTing Zhao
TingTing Zhao
DSDan Shi
Dan Shi
MYMing Bao Ye
Ming Bao Ye
QYQiying Yi
Qiying Yi

1 January 2020 in Gene
Verified
Journal Article
Closed access
QYQiying Yi
Qiying Yi
YLYang Liu
Yang Liu
MCMin Cao
Min Cao
JLJianing Liu
Jianing Liu
QXQin Xiang
Qin Xiang
YXYajun Xie
Yajun Xie

21 April 2021 in BioMetals
Verified
Journal Article
Closed access
PDF file
YMYijie Mao
Yijie Mao
LYLing Yao
Ling Yao
XJXuejun Jiang
Xuejun Jiang
GSGolamaully Sumayyah
Golamaully Sumayyah
ZZZhen Zou
Zhen Zou
CCChengzhi Chen
Chengzhi Chen

30 October 2020 in Journal of Microbiology and Biotechnology
Verified
Journal Article
Closed access
YXYajun Xie
Yajun Xie
PZPing Zhao
Ping Zhao
ZHZhigang Han
Zhigang Han
WLWei Li
Wei Li
DSDan Shi
Dan Shi
QYQiying Yi
Qiying Yi
Yajun Xie, Ping Zhao, Zhigang Han, Wei Li, Dan Shi, Lei Xu, Qiying Yi. J. Microbiol. Biotechnol. -0001;0:. https://doi.org/10.4014/jmb.2008.08003